Modelling Structure‐Activity Relationships
暂无分享,去创建一个
Darren V. S. Green | Emanuela Gancia | Gianpaolo Bravi | M. Hann | D. Green | E. Gancia | G. Bravi | Mike M. Hann
[1] Harpreet S. Chadha,et al. Hydrogen bonding. 33. Factors that influence the distribution of solutes between blood and brain. , 1994, Journal of pharmaceutical sciences.
[2] R. Venkataraghavan,et al. Atom pairs as molecular features in structure-activity studies: definition and applications , 1985, J. Chem. Inf. Comput. Sci..
[3] Paola Gramatica,et al. SD-modelling and Prediction by WHIM Descriptors. Part 5. Theory Development and Chemical Meaning of WHIM Descriptors , 1997 .
[4] R E Wilcox,et al. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors. , 1998, Journal of medicinal chemistry.
[5] G Vriend,et al. The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. , 1986, Science.
[6] G. Cruciani,et al. Generating Optimal Linear PLS Estimations (GOLPE): An Advanced Chemometric Tool for Handling 3D‐QSAR Problems , 1993 .
[7] D. E. Clark,et al. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration. , 1999, Journal of pharmaceutical sciences.
[8] Andrea Zaliani,et al. Global 3D-QSAR methods: MS-WHIM and autocorrelation , 2000, J. Comput. Aided Mol. Des..
[9] Allan M. Ferguson,et al. EVA: A new theoretically based molecular descriptor for use in QSAR/QSPR analysis , 1997, J. Comput. Aided Mol. Des..
[10] J. Mason,et al. New 4-point pharmacophore method for molecular similarity and diversity applications: overview of the method and applications, including a novel approach to the design of combinatorial libraries containing privileged substructures. , 1999, Journal of medicinal chemistry.
[11] G Klebe,et al. On the prediction of binding properties of drug molecules by comparative molecular field analysis. , 1993, Journal of medicinal chemistry.
[12] Peter Willett,et al. Effect of Parameter Variations on the Effectiveness of HQSAR Analyses , 1999 .
[13] Sung Jin Cho,et al. Rational Combinatorial Library Design. 2. Rational Design of Targeted Combinatorial Peptide Libraries Using Chemical Similarity Probe and the Inverse QSAR Approaches , 1998, J. Chem. Inf. Comput. Sci..
[14] Malcolm J. McGregor,et al. Pharmacophore Fingerprinting. 1. Application to QSAR and Focused Library Design , 1999, J. Chem. Inf. Comput. Sci..
[15] S. Free,et al. A MATHEMATICAL CONTRIBUTION TO STRUCTURE-ACTIVITY STUDIES. , 1964, Journal of medicinal chemistry.
[16] B. Kowalski,et al. Pattern recognition. II. Linear and nonlinear methods for displaying chemical data , 1973 .
[17] Ramaswamy Nilakantan,et al. Topological torsion: a new molecular descriptor for SAR applications. Comparison with other descriptors , 1987, J. Chem. Inf. Comput. Sci..
[18] A. Good,et al. New methodology for profiling combinatorial libraries and screening sets: cleaning up the design process with HARPick. , 1997, Journal of medicinal chemistry.
[19] D. Rogers,et al. Receptor surface models. 2. Application to quantitative structure-activity relationships studies. , 1995, Journal of medicinal chemistry.
[20] S. Ekins,et al. Three-dimensional quantitative structure activity relationship analyses of substrates for CYP2B6. , 1999, The Journal of pharmacology and experimental therapeutics.
[21] Teuvo Kohonen,et al. The self-organizing map , 1990 .
[22] J. Topliss,et al. Chance factors in studies of quantitative structure-activity relationships. , 1979, Journal of medicinal chemistry.
[23] Paul Labute,et al. Binary Quantitative Structure-Activity Relationship (QSAR) Analysis of Estrogen Receptor Ligands , 1999, J. Chem. Inf. Comput. Sci..
[24] Antti Poso,et al. Comparative Molecular Field Analysis of Compounds with CYP2A5 Binding Affinity , 1995 .
[25] Andrea Zaliani,et al. MS-WHIM Scores for Amino Acids: A New 3D-Description for Peptide QSAR and QSPR Studies , 1999, J. Chem. Inf. Comput. Sci..
[26] Peter W. Kenny,et al. Prediction of hydrogen bond basicity from computed molecular electrostatic properties: implications for comparative molecular field analysis , 1994 .
[27] Yvonne C. Martin,et al. A fast new approach to pharmacophore mapping and its application to dopaminergic and benzodiazepine agonists , 1993, J. Comput. Aided Mol. Des..
[28] Thuy Dao,et al. Comparative Spectra Analysis (CoSA): Spectra as Three-Dimensional Molecular Descriptors for the Prediction of Biological Activities , 1999, J. Chem. Inf. Comput. Sci..
[29] Lemont B. Kier,et al. Electrotopological State Indices for Atom Types: A Novel Combination of Electronic, Topological, and Valence State Information , 1995, J. Chem. Inf. Comput. Sci..
[30] Paul Geladi,et al. Principal Component Analysis , 1987, Comprehensive Chemometrics.
[31] Marina Lasagni,et al. New molecular descriptors for 2D and 3D structures. Theory , 1994 .
[32] Xin Chen,et al. Recursive Partitioning Analysis of a Large Structure-Activity Data Set Using Three-Dimensional Descriptors1 , 1998, J. Chem. Inf. Comput. Sci..
[33] H Matter,et al. Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins. , 1999, Journal of medicinal chemistry.
[34] D. E. Clark. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption. , 1999, Journal of pharmaceutical sciences.
[35] Robert P. Sheridan,et al. Chemical Similarity Using Geometric Atom Pair Descriptors , 1996, J. Chem. Inf. Comput. Sci..
[36] Peter Willett,et al. Evaluation of a novel infrared range vibration-based descriptor (EVA) for QSAR studies. 1. General application , 1997, J. Comput. Aided Mol. Des..
[37] R. Cramer,et al. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. , 1988, Journal of the American Chemical Society.
[38] Peter A. Hunt. QSAR using 2D descriptors and TRIPOS' SIMCA , 1999, J. Comput. Aided Mol. Des..
[39] Roberto Todeschini,et al. MS-WHIM, new 3D theoretical descriptors derived from molecular surface properties: A comparative 3D QSAR study in a series of steroids , 1997, J. Comput. Aided Mol. Des..
[40] T. Fujita,et al. Structure-activity study of phenethylamines as substrates of biosynthetic enzymes of sympathetic transmitters. , 1971, Journal of medicinal chemistry.
[41] P. Goodford. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. , 1985, Journal of medicinal chemistry.
[42] Romano T. Kroemer,et al. Replacement of steric 6–12 potential-derived interaction energies by atom-based indicator variables in CoMFA leads to models of higher consistency , 1995, J. Comput. Aided Mol. Des..
[43] W. Richards,et al. Self-organizing molecular field analysis: a tool for structure-activity studies. , 1999, Journal of medicinal chemistry.
[44] Svante Wold,et al. Multivariate Parametrization of 55 Coded and Non‐Coded Amino Acids , 1989 .
[45] Xin Chen,et al. Automated Pharmacophore Identification for Large Chemical Data Sets1 , 1999, J. Chem. Inf. Comput. Sci..
[46] J. Murray,et al. Correlations between the solvent hydrogen-bond-donating parameter .alpha. and the calculated molecular surface electrostatic potential , 1991 .
[47] M Pastor,et al. GRID/GOLPE 3D quantitative structure-activity relationship study on a set of benzamides and naphthamides, with affinity for the dopamine D3 receptor subtype. , 1997, Journal of medicinal chemistry.
[48] B D Silverman,et al. Comparative molecular moment analysis (CoMMA): 3D-QSAR without molecular superposition. , 1996, Journal of medicinal chemistry.
[49] C. Hansch,et al. p-σ-π Analysis. A Method for the Correlation of Biological Activity and Chemical Structure , 1964 .
[50] H. Kubinyi. QSAR: Hansch Analysis and Related Approaches: Kubinyi/QSAR , 1993 .
[51] Peter Ertl,et al. Simple Quantum Chemical Parameters as an Alternative to the Hammett Sigma Constants in QSAR Studies , 1997 .
[52] M. Hahn. Receptor surface models. 1. Definition and construction. , 1995, Journal of medicinal chemistry.
[53] G. Cruciani,et al. Comparative molecular field analysis using GRID force-field and GOLPE variable selection methods in a study of inhibitors of glycogen phosphorylase b. , 1994, Journal of medicinal chemistry.
[54] Han van de Waterbeemd,et al. Pattern recognition study of QSAR substituent descriptors , 1989, J. Comput. Aided Mol. Des..
[55] Robert P. Sheridan,et al. Chemical Similarity Using Physiochemical Property Descriptors , 1996, J. Chem. Inf. Comput. Sci..
[56] Klaus-Jürgen Schaper. FREE-WILSON-TYPE ANALYSIS OF NON-ADDITIVE SUBSTITUENT EFFECTS ON THPB DOPAMINE RECEPTOR AFFINITY USING ARTIFICIAL NEURAL NETWORKS , 1999 .
[57] J. Gasteiger,et al. Autocorrelation of Molecular Surface Properties for Modeling Corticosteroid Binding Globulin and Cytosolic Ah Receptor Activity by Neural Networks , 1995 .
[58] H. W. Hamilton,et al. Synthesis of xanthines as adenosine antagonists, a practical quantitative structure-activity relationship application. , 1985, Journal of medicinal chemistry.
[59] G. Folkers,et al. Quantitative Structure‐Activity Relationships of Phenyltropanes as Inhibitors of Three Monoamine Transporters: Classical and CoMFA studies , 1999 .
[60] D. J. Livingstone. Multivariate Data Display Using Neural Networks , 1996 .
[61] M G Rossmann,et al. Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses , 1990, Proteins.
[62] Shiyin Yee,et al. In Vitro Permeability Across Caco-2 Cells (Colonic) Can Predict In Vivo (Small Intestinal) Absorption in Man—Fact or Myth , 1997, Pharmaceutical Research.
[63] Sung-Sau So,et al. A comparative study of ligand-receptor complex binding affinity prediction methods based on glycogen phosphorylase inhibitors , 1999, J. Comput. Aided Mol. Des..
[64] Paola Gramatica,et al. Weighted holistic invariant molecular descriptors. Part 2. Theory development and applications on modeling physicochemical properties of polyaromatic hydrocarbons , 1995 .
[65] G Klebe,et al. Three-dimensional quantitative structure-activity relationship analyses using comparative molecular field analysis and comparative molecular similarity indices analysis to elucidate selectivity differences of inhibitors binding to trypsin, thrombin, and factor Xa. , 1999, Journal of medicinal chemistry.
[66] M Pastor,et al. Smart region definition: a new way to improve the predictive ability and interpretability of three-dimensional quantitative structure-activity relationships. , 1997, Journal of medicinal chemistry.